Young women's use of a vaginal microbicide surrogate: the role of individual and contextual factors in acceptability and sexual pleasure

J Sex Res. 2009 Jan-Feb;46(1):15-23. doi: 10.1080/00224490802398407.

Abstract

Currently in clinical trials, microbicides have historically been promoted as a woman-controlled (although more recently woman initiated) method of sexually transmitted infection (STI) prevention. The contradicition that exists in this rationale is that women's bodies, specifically the genitals, have been constructed as a negotiated space within sexual interactions. This study qualitatively explored the factors influencing 40 young women's use of a vaginal moisturizer (VM), utilized as a microbicide surrogate. The results indicated that use of the VM was dependent upon product characteristics (i.e., the lubricating qualities affect on sexual pleasure, timing of insertion), individual factors (i.e., reproductive health goals, experiences with side effects of existing contraceptive methods), and contextual factors (i.e., social norms). An understanding of these bodily and social issues may be beneficial in designing targeted educational campaigns and effective instructional materials as well as in facilitating positive dialogue around women's bodies and their sexuality.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Administration, Intravaginal
  • Adolescent
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use*
  • Contraceptive Agents, Female
  • Female
  • Health Knowledge, Attitudes, Practice*
  • Humans
  • Interviews as Topic
  • Longitudinal Studies
  • Midwestern United States
  • Patient Acceptance of Health Care* / ethnology
  • Patient Compliance / ethnology
  • Patient Compliance / psychology*
  • Personal Satisfaction*
  • Sexually Transmitted Diseases / prevention & control*
  • Sexually Transmitted Diseases / psychology
  • Women's Health
  • Young Adult

Substances

  • Anti-Infective Agents
  • Contraceptive Agents, Female